These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32391762)

  • 1. Early Anti-Xa Assay-Guided Low Molecular Weight Heparin Chemoprophylaxis Is Safe in Adult Patients with Acute Traumatic Brain Injury.
    Rodier SG; Kim M; Moore S; Frangos SG; Tandon M; Klein MJ; Berry CD; Huang PP; DiMaggio CJ; Bukur M
    Am Surg; 2020 Apr; 86(4):369-376. PubMed ID: 32391762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting.
    Rodier SG; Bukur M; Moore S; Frangos SG; Tandon M; DiMaggio CJ; Ayoung-Chee P; Marshall GT
    Eur J Trauma Emerg Surg; 2021 Feb; 47(1):145-151. PubMed ID: 31471669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.
    Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA
    J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care.
    Rakhra S; Martin EL; Fitzgerald M; Udy A
    Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective use of weight-based enoxaparin for deep vein thrombosis chemoprophylaxis in patients with traumatic brain injury.
    Taylor A; Martinez-Quinones P; Huang E; Robinson T; White CQ
    Am J Surg; 2022 Jan; 223(1):146-150. PubMed ID: 34340862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin.
    Imran JB; Madni TD; Clark AT; Rizk P; Huang E; Minshall CT; Taveras LR; Cunningham HB; Eastman AL; Koshy JP; Kacir CD; Cripps MW
    J Trauma Acute Care Surg; 2018 Nov; 85(5):867-872. PubMed ID: 29985229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprophylaxis and Venous Thromboembolism in Traumatic Brain Injury at Different Trauma Centers.
    Yeates EO; Grigorian A; Schubl SD; Kuza CM; Joe V; Lekawa M; Borazjani B; Nahmias J
    Am Surg; 2020 Apr; 86(4):362-368. PubMed ID: 32391761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury.
    Rivas L; Vella M; Ju T; Fernandez-Moure JS; Sparks A; Seamon MJ; Sarani B
    Am Surg; 2022 Feb; 88(2):187-193. PubMed ID: 33502231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin.
    May CC; Cua S; Smetana KS; Powers CJ
    World Neurosurg; 2022 Jan; 157():e357-e363. PubMed ID: 34655821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
    Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
    J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury.
    Farooqui A; Hiser B; Barnes SL; Litofsky NS
    J Neurosurg; 2013 Dec; 119(6):1576-82. PubMed ID: 24053504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients.
    Gates RS; Lollar DI; Collier BR; Smith J; Faulks ER; Gillen JR
    J Trauma Acute Care Surg; 2022 Jan; 92(1):93-97. PubMed ID: 34561398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early venous thromboembolism chemoprophylaxis in combat-related penetrating brain injury.
    Meyer RM; Larkin MB; Szuflita NS; Neal CJ; Tomlin JM; Armonda RA; Bailey JA; Bell RS
    J Neurosurg; 2017 Apr; 126(4):1047-1055. PubMed ID: 27315028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
    Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
    Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis.
    Berndtson AE; Costantini TW; Lane J; Box K; Coimbra R
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1095-1100. PubMed ID: 27244575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.